Must listen, read, and watch 

• A September 23, 2014 NPR article reported that Justin McCowan, "a man with Down syndrome who wanted to help researchers find a treatment for Alzheimer's disease" passed away this week at the age of 40. Justin was the focus of a recent Morning Edition story about the overlap between Down syndrome and Alzheimer's. According to the article, "McCowan volunteered for a month-long study of an experimental Alzheimer's drug at the University of California, San Diego. He decided he was willing to undergo the brain scans and blood tests involved because he saw it as a way to help his friend Maria, who also has Down syndrome and had developed Alzheimer's. "I feel very sad about Maria because she doesn't remember anything," McCowan said."
• A September 22, 2014 BBC News broadcast interview with Professor Susan Greenfield explored the need for a new "left of field" approach to finding a cure for Alzheimer's. Baroness Susan Greenfield is a British scientist, writer, broadcaster, and member of the House of Lords.
• A September 22, 2014 CNN article reported that Alzheimer's sufferer and ActivistAgainstAlzheimer's member Sandy Halperin will join Ruth Drew, director of family and information services for the Alzheimer's Association, and CNN producer Stephanie Smith for a discussion about Alzheimer's on CNN.com on Tuesday, September 23 at 3 p.m. EST. Join here: http://www.cnn.com/2014/09/22/health/alzheimers-discussion/ 
• A September 22, 2014 News Observer (NC) opinion piece by Amy Shyshnyak underscored the need to participate in Alzheimer's clinical trials. According to Shyshnyak, "What's missing are people who are willing to step up and move this research forward. One of the biggest misconceptions about clinical trials is that researchers mostly study people who already suffer the disease. On the contrary, much of the Alzheimer's research on the horizon needs individuals without symptoms. And, because most trials require specific criteria for participation, scientists must consider thousands of potential participants, which can delay research significantly…What can you do to help? As a healthy person with no symptoms of the disease, one of the easiest ways to get involved is enrolling in the registry and exploring possibilities of participating in this exciting new frontier of Alzheimer's research. Take one minute out of your day to join me in signing up."